Advanced search

Genetic variation of HIV type 1: Relevance of interclade variation to vaccine development.

Author

Citation

Please use this url to cite or link to this publication:

Chicago
VAN DER GROEN, G, PN NYAMBI, E BEIRNAERT, D DAVIS, K FRANSEN, L HEYNDRICKX, P ONDOA, G VAN DER AUWERA, and W JANSSENS. 1998. “Genetic Variation of HIV Type 1: Relevance of Interclade Variation to Vaccine Development.” Aids Research and Human Retroviruses (S211-S221 Suppl. 3).
APA
VAN DER GROEN, G., NYAMBI, P., BEIRNAERT, E., DAVIS, D., FRANSEN, K., HEYNDRICKX, L., ONDOA, P., et al. (1998). Genetic variation of HIV type 1: Relevance of interclade variation to vaccine development. AIDS RESEARCH AND HUMAN RETROVIRUSES, (S211-S221 Suppl. 3).
Vancouver
1.
VAN DER GROEN G, NYAMBI P, BEIRNAERT E, DAVIS D, FRANSEN K, HEYNDRICKX L, et al. Genetic variation of HIV type 1: Relevance of interclade variation to vaccine development. AIDS RESEARCH AND HUMAN RETROVIRUSES. 1998;(S211-S221 Suppl. 3).
MLA
VAN DER GROEN, G, PN NYAMBI, E BEIRNAERT, et al. “Genetic Variation of HIV Type 1: Relevance of Interclade Variation to Vaccine Development.” AIDS RESEARCH AND HUMAN RETROVIRUSES S211-S221 Suppl. 3 (1998): n. pag. Print.
@article{180487,
  author       = {VAN DER GROEN, G and NYAMBI, PN and BEIRNAERT, E and DAVIS, D and FRANSEN, K and HEYNDRICKX, L and ONDOA, P and VAN DER AUWERA, G and JANSSENS, W},
  issn         = {0889-2229},
  journal      = {AIDS RESEARCH AND HUMAN RETROVIRUSES},
  language     = {eng},
  number       = {S211-S221 Suppl. 3},
  title        = {Genetic variation of HIV type 1: Relevance of interclade variation to vaccine development.},
  year         = {1998},
}

Web of Science
Times cited: